Company Profiles

driven by the PitchBook Platform

Adenovir Pharma

Description

Developer of pharmaceutical products for the treatment of a viral eye infection. The company is focused on development of a topical antiviral pharmaceutical product for treatment and potential use for prevention of adenoviral conjunctivitis, epidemic keratoconjunctivitis (EKC).

2008

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$677k

Latest Deal Amount

$6.99M

Total Amount Raised

Description

Developer of pharmaceutical products for the treatment of a viral eye infection. The company is focused on development of a topical antiviral pharmaceutical product for treatment and potential use for prevention of adenoviral conjunctivitis, epidemic keratoconjunctivitis (EKC).

Website:

www.adenovir.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Kullagatan 8 252 20 HelsingborgSweden +46 (0)42 38 74 28
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Adenovir Pharma's full profile, request a free trial.

    Adenovir Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Adenovir Pharma Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AugmentaVenture CapitalMinority000 0000000 0000
    BWGPE-Backed CompanyMinority000 0000000 0000
    LänsförsäkringarLimited PartnerMinority000 0000000 0000
    Partners for Development Investments in Life SciencesAccelerator/IncubatorMinority000 0000000 0000
    Sätila HoldingOtherMinority000 0000000 0000
    Augmenta Venture Capital
    BWG PE-Backed Company
    Länsförsäkringar Limited Partner
    Partners for Development Investments in Life Sciences Accelerator/Incubator
    Sätila Holding Other

    Adenovir Pharma Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Björn DellgrenChief Executive Officer & Project Leader
    Björn Dellgren Chief Executive Officer & Project Leader

    Adenovir Pharma Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Björn Lundgren Ph.DSelfBoard Member000 0000
    Göran Wadell MDSelfBoard Member000 0000
    Karin WingstrandSelfBoard Member000 0000
    Kjell Oberg Ph.DSelfDeputy Board Member000 0000
    Lennart BruceSelfBoard Member000 0000
    Björn Lundgren Ph.D Board Member Self
    Göran Wadell MD Board Member Self
    Karin Wingstrand Board Member Self
    Kjell Oberg Ph.D Deputy Board Member Self
    Lennart Bruce Board Member Self
    Request full access to PitchBook